Infinity Pharmaceuticals Inc banner

Infinity Pharmaceuticals Inc
F:I3F

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
F:I3F
Watchlist
Price: 0.0171 EUR 3.64%
Market Cap: €1.5m

Wall St Price Targets

I3F Price Targets Summary
Infinity Pharmaceuticals Inc

There are no price targets for I3F.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Infinity Pharmaceuticals Inc Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
9% Upside
CSGP
CoStar Group Inc
18% Upside

Revenue
Forecast

-20% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-20% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -20%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is I3F's stock price target?
Not Available

I3F does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett